These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 10644334)

  • 1. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.
    Giavedoni LD; Velasquillo MC; Parodi LM; Hubbard GB; Hodara VL
    J Virol; 2000 Feb; 74(4):1648-57. PubMed ID: 10644334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
    Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
    J Virol; 2018 May; 92(9):. PubMed ID: 29467313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.
    Kenway-Lynch CS; Das A; Lackner AA; Pahar B
    J Virol; 2014 Aug; 88(16):9442-57. PubMed ID: 24920807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.
    Vargas-Inchaustegui DA; Xiao P; Demberg T; Pal R; Robert-Guroff M
    Immunology; 2015 Jun; 145(2):288-99. PubMed ID: 25626488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.
    Pallikkuth S; Rogers K; Villinger F; Dosterii M; Vaccari M; Franchini G; Pahwa R; Pahwa S
    Vaccine; 2011 Nov; 29(49):9229-38. PubMed ID: 21996099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Perturbation of Mucosal Group 3 Innate Lymphoid and Natural Killer Cells in Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus-Infected Infant Rhesus Macaques.
    Hueber B; Curtis AD; Kroll K; Varner V; Jones R; Pathak S; Lifton M; Van Rompay KKA; De Paris K; Reeves RK
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
    Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD
    J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection.
    Kaur A; Hale CL; Ramanujan S; Jain RK; Johnson RP
    J Virol; 2000 Sep; 74(18):8413-24. PubMed ID: 10954541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
    Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
    J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection.
    Meythaler M; Martinot A; Wang Z; Pryputniewicz S; Kasheta M; Ling B; Marx PA; O'Neil S; Kaur A
    J Virol; 2009 Jan; 83(2):572-83. PubMed ID: 18987149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
    Metzner KJ; Moretto WJ; Donahoe SM; Jin X; Gettie A; Montefiori DC; Marx PA; Binley JM; Nixon DF; Connor RI
    J Gen Virol; 2005 Dec; 86(Pt 12):3375-3384. PubMed ID: 16298985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection.
    Rout N; Greene J; Yue S; O'Connor D; Johnson RP; Else JG; Exley MA; Kaur A
    PLoS Pathog; 2012 Sep; 8(9):e1002928. PubMed ID: 23028326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.
    Wang Z; Metcalf B; Ribeiro RM; McClure H; Kaur A
    J Virol; 2006 Mar; 80(6):2771-83. PubMed ID: 16501086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.
    Schafer JL; Li H; Evans TI; Estes JD; Reeves RK
    J Virol; 2015 Jul; 89(13):6887-94. PubMed ID: 25903330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates.
    Villinger F; Folks TM; Lauro S; Powell JD; Sundstrom JB; Mayne A; Ansari AA
    Immunol Lett; 1996 Jun; 51(1-2):59-68. PubMed ID: 8811346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: a proof of concept study in macaques.
    Koopman G; Beenhakker N; Hofman S; Walther-Jallow L; Mäkitalo B; Mooij P; Anderson J; Verschoor E; Bogers WM; Heeney JL; Spetz AL
    Vaccine; 2012 Mar; 30(15):2523-34. PubMed ID: 22314133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early activation and proliferation of T cells in simian immunodeficiency virus-infected rhesus monkeys.
    Sopper S; Sauer U; Müller JG; Stahl-Hennig C; ter Meulen V
    AIDS Res Hum Retroviruses; 2000 May; 16(7):689-97. PubMed ID: 10791879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages and Myeloid Dendritic Cells Lose T Cell-Stimulating Function in Simian Immunodeficiency Virus Infection Associated with Diminished IL-12 and IFN-α Production.
    Wonderlich ER; Wu WC; Normolle DP; Barratt-Boyes SM
    J Immunol; 2015 Oct; 195(7):3284-92. PubMed ID: 26297760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.